Fate Therapeutics Receives $8,000,000 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=35cf3b9d-cb34-4973-9953-0555e6611a86
Date
5/18/2015
Company Name
Fate Therapeutics
Mailing Address
3535 General Atomics Court San Diego, CA 92121 USA
Company Description
The company’s revolutionary platform focuses on both regenerative and reprogramming medicine. Fate’s regenerative medicine platform involves developing drugs that awaken adult stem cells in the body to repair damaged cells and tissues.
Website
http://www.fatetherapeutics.com
Transaction Type
Venture Equity
Transaction Amount
$8,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor